BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17035405)

  • 21. Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population.
    Chiusolo P; Reddiconto G; Cimino G; Sica S; Fiorini A; Farina G; Vitale A; Sorà F; Laurenti L; Bartolozzi F; Fazi P; Mandelli F; Leone G
    Haematologica; 2004 Feb; 89(2):139-44. PubMed ID: 15003888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
    Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients.
    Chatzidakis K; Goulas A; Athanassiadou-Piperopoulou F; Fidani L; Koliouskas D; Mirtsou V
    Pediatr Blood Cancer; 2006 Aug; 47(2):147-51. PubMed ID: 16123993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis.
    Sun L; Sun YH; Wang B; Cao HY; Yu C
    Eur J Cancer Prev; 2008 Oct; 17(5):446-52. PubMed ID: 18714187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the association between 5,10-methylenetrahydrofolate reductase C677T polymorphism and acute lymphoblastic leukemia risk: a Meta-analysis].
    Li XL; Yu F; Zhang Y; Qiu JC; Liu ST; Liao QC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Oct; 32(10):1030-6. PubMed ID: 22333090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.
    Kim JK; Kim S; Han JH; Kim HJ; Chong SY; Hong SP; Hwang SG; Ahn JY; Cha KY; Oh D; Kim NK
    Anticancer Res; 2005; 25(3B):2249-52. PubMed ID: 16158971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
    Hur M; Park JY; Cho HC; Lee KM; Shin HY; Cho HI
    Clin Lab Haematol; 2006 Jun; 28(3):154-9. PubMed ID: 16706930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.
    Ouerhani S; Oliveira E; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; El Gaaied AB; Prata MJ
    Cancer Genet Cytogenet; 2007 Jul; 176(1):48-53. PubMed ID: 17574963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.
    Pei JS; Hsu CM; Tsai CW; Chang WS; Ji HX; Hsiao CL; Miao CE; Hsu YN; Bau DT
    PLoS One; 2015; 10(3):e0119776. PubMed ID: 25793509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis.
    Rubino E; Ferrero M; Rainero I; Binello E; Vaula G; Pinessi L
    Cephalalgia; 2009 Aug; 29(8):818-25. PubMed ID: 17714520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
    Schnakenberg E; Mehles A; Cario G; Rehe K; Seidemann K; Schlegelberger B; Elsner HA; Welte KH; Schrappe M; Stanulla M
    BMC Med Genet; 2005 May; 6():23. PubMed ID: 15921520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MTHFR polymorphisms and risk of chronic lymphocytic leukemia.
    Rudd MF; Sellick GS; Allinson R; Matutes E; Catovsky D; Houlston RS
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2268-70. PubMed ID: 15598791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.
    Li SY; Ye JY; Liang EY; Zhou LX; Yang M
    Med Sci Monit; 2015 Mar; 21():740-8. PubMed ID: 25761797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population.
    Zanrosso CW; Hatagima A; Emerenciano M; Ramos F; Figueiredo A; Félix TM; Segal SL; Giugliani R; Muniz MT; Pombo-de-Oliveira MS
    Leuk Res; 2006 Apr; 30(4):477-81. PubMed ID: 16182363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma.
    Ismail SI; Ababneh NA; Khader Y; Abu-Khader AA; Awidi A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):120-4. PubMed ID: 19963111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia.
    Robien K; Ulrich CM; Bigler J; Yasui Y; Gooley T; Bruemmer B; Potter JD; Radich JP
    Clin Cancer Res; 2004 Nov; 10(22):7592-8. PubMed ID: 15569990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia.
    Golbahar J; Aminzadeh MA; Al-Shboul QM; Kassab S; Rezaian GR
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):462-7. PubMed ID: 17010581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.